The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcome of sequential chemotherapy after immune checkpoint inhibitors in advanced ovarian cancer.
 
Luisa Bonilla
No Relationships to Disclose
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - AstraZeneca (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Sam Saibil
No Relationships to Disclose
 
Shiyi Chen
No Relationships to Disclose
 
Yeh Chen Lee
No Relationships to Disclose
 
Diana Gray
No Relationships to Disclose
 
Ilaria Colombo
Employment - Medtronic (I)
Stock and Other Ownership Interests - Medtronic (I)
 
Ainhoa Madariaga
No Relationships to Disclose
 
Neesha C. Dhani
Honoraria - Celgene; Sanofi
Consulting or Advisory Role - Celgene; Incyte
 
Gita Bhat
No Relationships to Disclose
 
Valerie Bowering
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Swati Garg
No Relationships to Disclose
 
Daniel Yokom
No Relationships to Disclose
 
Sunu Lazar Cyriac
No Relationships to Disclose
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Bristol-Myers Squibb; EMD Serono; Genzyme; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Immunocore; Immunovaccine; Merck; Novartis
Research Funding - Merck; Takara Bio
Expert Testimony - Merck